KYTX - Kyverna Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KYTX is currently covered by 4 analysts with an average price target of $31. This is a potential upside of $25.33 (446.74%) from yesterday's end of day stock price of $5.67.

Kyverna Therapeutics's activity chart (see below) currently has 23 price targets and 22 ratings on display. The stock rating distribution of KYTX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.15% with an average time for these price targets to be met of 22.88 days.

Highest price target for KYTX is $33, Lowest price target is $25, average price target is $31.

Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 03-Jun-2026. First documented stock forecast 04-Mar-2024.

Best performing analysts who are covering KYTX - Kyverna Therapeutics:

Mitchell Kapoor Brian Cheng Derek Archila Michael Ulz

Currently out of the existing stock ratings of KYTX, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Aug-2025

$25

$19.33 (340.92%)

$25

4 months 29 days ago
(03-Jun-2026)

9/13 (69.23%)

$17.18 (219.69%)

92

Buy Since 04-Mar-2024

$29

$23.33 (411.46%)

$33

5 months 19 days ago
(13-May-2026)

0/3 (0%)

$18.22 (169.02%)

Buy Since 08-Oct-2025

$33

$27.33 (482.01%)

$31

10 months 16 days ago
(16-Dec-2025)

0/3 (0%)

$22.76 (222.27%)

Buy Since 04-Mar-2024

$33

$27.33 (482.01%)

10 months 17 days ago
(15-Dec-2025)

0/2 (0%)

$22.18 (204.99%)

Show more analysts

Please expand the browser size to see the chart

What is KYTX (Kyverna Therapeutics) average time for price targets to be met?

On average it took 23 days for the stock forecasts to be reached, with an average price target met ratio of 21.15%.

Which analyst most recently updated their price target on KYTX (Kyverna Therapeutics)?

Mitchell Kapoor

Which analyst has the most public recommendations on KYTX (Kyverna Therapeutics)?

Mitchell Kapoor has 9 price targets and 7 ratings on KYTX

Which analyst is the currently most bullish on KYTX (Kyverna Therapeutics)?

Michael Ulz with the highest potential upside of $27.33

Which analyst is the currently most reserved on KYTX (Kyverna Therapeutics)?

Mitchell Kapoor with the lowest potential downside of -$3.44
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?